C4 Therapeutics (CCCC) Leases (2019 - 2025)
Historic Leases for C4 Therapeutics (CCCC) over the last 7 years, with Q3 2025 value amounting to $42.0 million.
- C4 Therapeutics' Leases fell 2908.04% to $42.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $42.0 million, marking a year-over-year decrease of 2908.04%. This contributed to the annual value of $57.5 million for FY2024, which is 1003.82% down from last year.
- Per C4 Therapeutics' latest filing, its Leases stood at $42.0 million for Q3 2025, which was down 2908.04% from $54.2 million recorded in Q2 2025.
- C4 Therapeutics' 5-year Leases high stood at $74.8 million for Q1 2022, and its period low was $12.2 million during Q3 2021.
- Moreover, its 5-year median value for Leases was $60.8 million (2024), whereas its average is $53.5 million.
- As far as peak fluctuations go, C4 Therapeutics' Leases skyrocketed by 48468.45% in 2022, and later plummeted by 2908.04% in 2025.
- Over the past 5 years, C4 Therapeutics' Leases (Quarter) stood at $31.9 million in 2021, then soared by 119.49% to $70.1 million in 2022, then decreased by 8.79% to $64.0 million in 2023, then dropped by 10.04% to $57.5 million in 2024, then fell by 27.07% to $42.0 million in 2025.
- Its Leases was $42.0 million in Q3 2025, compared to $54.2 million in Q2 2025 and $55.9 million in Q1 2025.